Bioethicist by training, Dr. Bélisle-Pipon is conducting research at the interface of health policy, citizen and patient engagement in research and health governance, as well as business practices. His professional experience, having worked for both the pharmaceutical industry and the government, provided him with an insider’s understanding of the ethical, policy and societal dimensions of health technology development and assessment. Dr. Bélisle-Pipon uses both empirical and conceptual bioethics methodologies to make recommendations on the appropriate management and resolution of ethical issues for health regulators and industry decision-makers. He carried out his CIHR-funded postdoctoral fellowship at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at the Harvard Law School (2017-2020) and pursued a second fellowship at McGill University (2020). He was member of the Board of Directors of Québec Health Research Fund and currently serves on the Board of Directors of the International Association of Bioethics. Dr. Bélisle-Pipon joined the Faculty of Health Sciences in 2021.

Research Interests:

Bioethics; Applied Ethics; Empirical Bioethics; Health Policy; Ethics of Artificial Intelligence; Health Technology Assessment; Citizen Engagement; Conflict of Interest; Patient-Oriented Research; Ethics of Drug Marketing and Commercialization; Business Ethics; Corporate Social Responsibility